Sub-study of GSK Protocol TB-018: Collection and storage of biological samples for evaluation of correlates of tuberculosis

Trial Profile

Sub-study of GSK Protocol TB-018: Collection and storage of biological samples for evaluation of correlates of tuberculosis

Completed
Phase of Trial: Phase IV

Latest Information Update: 06 Feb 2017

At a glance

  • Drugs GSK 692342 (Primary)
  • Indications Tuberculosis
  • Focus Biomarker; Therapeutic Use
  • Sponsors Aeras
  • Most Recent Events

    • 31 Jan 2017 Status changed from active, no longer recruiting to completed.
    • 03 Feb 2016 Planned End Date changed from 1 Aug 2017 to 1 Nov 2016, according to ClinicalTrials.gov record.
    • 03 Feb 2016 Planned primary completion date changed from 1 Aug 2017 to 1 Nov 2016, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top